Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,033 | 60 | 43.0% |
| Education | $1,500 | 1 | 31.7% |
| Travel and Lodging | $1,194 | 7 | 25.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $2,816 | 10 | $0 (2024) |
| NxThera, Inc. | $241.46 | 2 | $0 (2018) |
| Boston Scientific Corporation | $237.08 | 6 | $0 (2023) |
| Agiliti Surgical, Inc. | $151.61 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $149.03 | 3 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $123.06 | 1 | $0 (2017) |
| Dornier MedTech America, Inc | $104.94 | 1 | $0 (2023) |
| Olympus America Inc. | $99.77 | 4 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $97.62 | 5 | $0 (2024) |
| Amgen Inc. | $93.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $755.36 | 14 | INTUITIVE SURGICAL, INC. ($532.26) |
| 2023 | $645.02 | 22 | Agiliti Surgical, Inc. ($151.61) |
| 2022 | $2,330 | 10 | Intuitive Surgical, Inc. ($2,284) |
| 2021 | $36.99 | 2 | AbbVie Inc. ($25.13) |
| 2020 | $68.50 | 2 | Olympus America Inc. ($55.22) |
| 2019 | $119.72 | 2 | Amgen Inc. ($93.17) |
| 2018 | $484.33 | 9 | NxThera, Inc. ($136.80) |
| 2017 | $286.83 | 7 | Janssen Scientific Affairs, LLC ($123.06) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $115.95 | General |
| Category: SURGERY | ||||||
| 11/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $410.31 | General |
| Category: SURGERY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 09/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 04/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/31/2023 | Dornier MedTech America, Inc | Dornier MedTech (Device) | Food and Beverage | In-kind items and services | $104.94 | General |
| Category: Not Applicable | ||||||
| 11/16/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 11/11/2023 | Agiliti Surgical, Inc. | Sonablate (Device) | Food and Beverage | Cash or cash equivalent | $151.61 | General |
| Category: Surgical lasers | ||||||
| 10/17/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Oncology | ||||||
| 08/17/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/15/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Oncology | ||||||
| 07/18/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Oncology | ||||||
| 07/14/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: HORMONE THERAPY | ||||||
| 06/22/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: HORMONE THERAPY | ||||||
| 06/15/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $14.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,976 | 2,724 | $544,287 | $169,215 |
| 2022 | 25 | 2,220 | 3,197 | $663,516 | $207,962 |
| 2021 | 31 | 2,262 | 2,988 | $644,245 | $200,295 |
| 2020 | 29 | 2,124 | 2,828 | $550,456 | $171,101 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 478 | 679 | $159,684 | $62,225 | 39.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 91 | 105 | $60,375 | $19,754 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 172 | 243 | $38,880 | $15,967 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 103 | $32,342 | $13,420 | 41.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 105 | $99,750 | $13,005 | 13.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $26,904 | $8,728 | 32.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 14 | 59 | $14,514 | $4,202 | 29.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 15 | $12,300 | $3,603 | 29.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $14,300 | $3,540 | 24.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 41 | 42 | $14,238 | $3,405 | 23.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $4,675 | $2,352 | 50.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,757 | $2,279 | 33.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 13 | 13 | $9,880 | $2,238 | 22.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $8,878 | $2,230 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 32 | $2,944 | $2,053 | 69.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,772 | $1,936 | 33.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 555 | 825 | $8,250 | $1,804 | 21.9% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 39 | 40 | $6,920 | $1,508 | 21.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 23 | $4,255 | $1,387 | 32.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 137 | 152 | $6,232 | $1,245 | 20.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 27 | $2,511 | $693.13 | 27.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 15 | 15 | $2,580 | $671.73 | 26.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $540.00 | $496.53 | 92.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 11 | $572.00 | $241.20 | 42.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 39 | $234.00 | $229.32 | 98.0% |
About Dr. Bradley Rosenberg, MD
Dr. Bradley Rosenberg, MD is a Urology healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295718559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Rosenberg, MD has received a total of $4,727 in payments from pharmaceutical and medical device companies, with $755.36 received in 2024. These payments were reported across 68 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,033).
As a Medicare-enrolled provider, Rosenberg has provided services to 8,582 Medicare beneficiaries, totaling 11,737 services with total Medicare billing of $748,573. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Royal Oak, MI
- Active Since 11/21/2005
- Last Updated 07/14/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1295718559
Products in Payments
- DA VINCI SP (Device) $1,500
- Da Vinci Surgical System (Device) $1,316
- Rezum (Device) $241.46
- Sonablate (Device) $151.61
- INVOKANA (Drug) $123.89
- DARZALEX (Biological) $123.06
- EMBOZENE (Device) $113.76
- Dornier MedTech (Device) $104.94
- ADSTILADRIN (Biological) $97.62
- WaveWriter Alpha Prime 16 (Device) $96.33
- Prolia (Biological) $93.17
- Olympus Laser Devices (Device) $72.53
- ERLEADA (Drug) $67.33
- JELMYTO (Drug) $54.95
- Noctiva (Drug) $45.22
- Xtandi (Drug) $38.16
- ORGOVYX (Drug) $32.82
- VIBERZI (Drug) $29.05
- iTIND System (Device) $27.24
- PROVENGE (Drug) $25.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Royal Oak
Richard Bennett, Md, MD
Urology — Payments: $607,905
Dr. Kenneth Peters, Md, MD
Urology — Payments: $26,596
Adam Gadzinski, M.d, M.D
Urology — Payments: $18,520
Dr. Jason Gilleran, Md, MD
Urology — Payments: $14,239
Melissa Fischer, Md, MD
Urology — Payments: $11,402
Dr. Hamza Beano, M.d, M.D
Urology — Payments: $8,264